Latest filing published 02 Oct 2026 for Alphabet Inc., €25k. Read the official filing
Frances Arnold, listed as senior executive, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Alphabet Inc., Illumina, Inc. and Generate Biomedicines, Inc. In total, 77 filings cover trades dated from 27 January 2016 to 30 September 2026.
Sales make up the whole of the open-market record (41 sales, €1.3M). The totals exclude 1 filing filed without an amount. Besides market trades, the filings include 35 share grants. Since January 2026: no purchases and 10 sales on the market.
The latest filing, published on 2 October 2026, reports an open-market sale of €25k in Alphabet Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 77 declarations